Turnover
≈ €650,000 estimated
The micro format states no turnover.
LAFLOR
Lifetime
1 annual account with figurespeak €430,137 (2025)
€430,137
peak €289,529 (2025)
€289,529
peak €289,696 (2025)
€289,696
€99,784
Board1 name since 2024
1 director
Documentsfilings and deeds
06-07-202625 days before the deadline
2025micro format
Dividend €833First year with figures
Key points
from the 2025 annual accountsStarting capital
€1,000 100 shares
Position in the sector
€289,529
Higher net result than 95% of companies in human health. Sector median €59,542 · 21,298 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 11,278 companies had the same profile as LAFLOR has now. Each dot stands for 29 companies, two years later.
96.6%
were still trading
2.6%
stopped another way
0.7%
went bankrupt
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 11,278 companies, not a prediction for LAFLOR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1016214263
Incorporation
Founding capital of €1,000, 100 shares · Founder: · Appointment: (director) · published on 19-11-2024 · Gazette deed
First establishment
Charleroise Steenweg 146, Sint-Gillis (bij-Brussel)
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| LAFLOR Sint-Gillis (bij-Brussel) | €389,479 | €430,137 | 74.4% | - |
| Thomas LEPERS - Anesthésie Sint-Gillis (bij-Brussel) | €376,554 | €384,309 | 75.2% | - |
| HAKAMEYE Vilvoorde | €414,172 | €429,894 | 72.8% | - |
| BF Resp Oncology Overijse | €434,641 | €422,084 | 73.4% | - |
| Dr. Jeroen Boons Heist-op-den-Berg | €368,254 | €385,272 | 73.2% | - |
| LLC CONSULTING Woluwe-Saint-Lambert | €409,529 | €362,714 | 77.7% | - |
| PJRJ Uccle | €437,797 | €354,519 | 51.8% | - |
These companies have the same main activity as LAFLOR: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €368,000 and €438,000, founded between 2024 and 2025.
Official details
Source: KBO- Status
- Active since 14-11-2024Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.366.390.1251060 Sint-Gillis (bij-Brussel), since 14-11-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 16-12-2025
Annual accounts 2025
- €389,479
- Filing
- Filed on 06-07-2026, 25 days before the end of the filing period
Insights on LAFLOR
LAFLOR has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €289,696 and a net result of €289,529.
Its solvency ranks better than 62% of 21,311 sector peers (NACE 86, financial year 2025).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about LAFLOR
- What is the company number of LAFLOR?
- The company number of LAFLOR is 1016.214.263. The VAT number is the same number with BE in front: BE 1016.214.263.
- Where is LAFLOR based?
- The registered office is at Charleroise Steenweg 146, 1060 Sint-Gillis (bij-Brussel).Company details
- What does LAFLOR do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of LAFLOR?
- LAFLOR is a private limited company (BV).
- When was LAFLOR founded?
- LAFLOR was founded on 14-11-2024.
- Is LAFLOR still active?
- Yes, LAFLOR is an active enterprise in the KBO register.
- What is the turnover of LAFLOR?
- The turnover in financial year 2025 is ≈ €650,000. This figure is estimated from the gross margin of €430,137 and 30 comparable companies (NACE 86220). It probably lies between €580,000 and €900,000.Financials
- Is LAFLOR profitable?
- In financial year 2025, LAFLOR made a profit of €289,529.
- Where can I find the annual accounts of LAFLOR?
- LAFLOR filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark Estimate what this company is worth.Value indication
See how customers, suppliers and banks see your own company and what to improve first.